CFTR and dry eye syndrome: In human ocular surface, increasing the fluid transport via CFTR activators can induce sustained flow of water compared to the transient activation of calcium-activated chloride channels with the P2Y2 agonist [13], and these results strongly suggest that CFTR activators are potential agents for the treatment of dry eye.